Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium, totam rem aperiam, eaque ipsa quae ab illo inventore veritatis et quasi architecto beatae vitae dicta sunt explicabo.
The range of risk facing executives has increased significantly in recent years, and even before the pandemic, life science companies were more likely to face litigation than other industries. A challenging hard market coupled with heightened risk of lawsuits impact your business in unforeseen ways. As you prepare for investor meetings during the JP Morgan Life Science Conference, we invite you to join us for a discussion on trends that will have significant risk implications for senior management in 2021 and beyond.
Thursday, January 7th, 2021
10:00am - 11:00am PT
This webinar will be recorded for future listening and will be emailed to all registrants. You can submit your questions in advance to [email protected] and we will try to address during the webinar.
Topics for Discussion
SPAC landscape
Covid impacts
Federal forum provisions
Shareholder litigation
Officer liability
Sed ut perspiciatis unde omnis iste natus error sit voluptatem!
Nemo enim ipsam voluptatem quia voluptas sit odit aut fugit!
Ut enim ad minima veniam, quis nostrum exercitationem ullam!
Partner and Chair, Securities Litigation Practice Group
Cooley LLP
Partner
Cooley LLP
SVP, National Claims Services and Client Engagement
ABD
SVP, National Claims Services and Client Engagement
ABD
xx
xx
Title
Company